Qvar Redihaler generic
Qvar Redihaler is an aerosol, metered; inhalation drug owned by Norton Waterford. The active ingredient is beclomethasone dipropionate. It was first authorized for market use on 03 August, 2017. Qvar Redihaler has a total of 13 patents.
When will Qvar Redihaler generic be available?
The generic version of Qvar Redihaler is expected to become available after 19 August, 2041. This release date is estimated based on the expiration of the last patent listed (US11583643), which expires on 2041-08-19.
Qvar Redihaler uses
Qvar Redihaler with its active ingredient beclomethasone dipropionate is used to treat various conditions. Detailed information about its specific uses can be found on its official product page.
Qvar Redihaler patent expiration
Qvar Redihaler has several patents covering various aspects, with the last one expiring on 19 August, 2041 (US11583643). This patent covers inhalers and related methods. For more details about Qvar Redihaler generic and the patents, see below: